First-in-human study of dual-imaging catheter to assess heart attack risk, guide treatment

Researchers astatine the UC Davis National Center for Interventional Biophotonic Technologies (NCIBT) person concluded the first-in-human trial of a caller instrumentality that could assistance doctors amended observe and dainty atherosclerosis, the narrowing of humor vessels owed to plaque buildup. The flexible catheter-based device, developed astatine NCIBT labs, is designed to navigate the interior walls of arteries and seizure elaborate accusation astir plaque buildup successful existent time.